The US drugstore chain, CVS Health, has paid $535,000 to federal prosecutors to resolve allegations that it fulfilled prescriptions that it should have known to be fraudulent. The charges relate to the drug Percocet which contains the opioid oxycodone. The chain denies the charges and stated that it paid out to avoid the “delay, uncertainty and expense of litigation.” Also, the head of Insys Therapeutics, John Kapoor, and four company executives have been found guilty on charges relating to the distribution of Subsys, a fentanyl-based spray approved for terminal cancer patients. The court found that Kapoor had effectively bribed doctors to prescribe large amounts of Subsys to patients while the executives were convicted on charges related to racketeering. John Kapoor and the executives each face up to 20 years in prison.